Researchers Identify Common Immune Response Patterns in Brain Tissue, Offering New Hope for Neurological Disease Therapies
A new study published on March 25, 2026, in Nature Immunology reveals that despite the diverse ways neurological diseases manifest, the brain’s immune system utilizes similar reaction patterns when responding to conditions like Alzheimer’s disease, multiple sclerosis, and brain tumors. This discovery, made by researchers at the University of Freiburg’s Medical Faculty in Germany, alongside an international team, could pave the way for more targeted therapies for these debilitating illnesses. Understanding how the brain defends itself is a critical step in developing effective treatments.
The research team analyzed human brain tissue from patients with various central nervous system disorders, and complemented these findings with analyses of mouse models. They created detailed maps illustrating where specific immune cells are active during disease progression, providing crucial insights into their function. “Our results show that immune cells in the brain react according to similar patterns in different diseases. The immune system has a manageable number of building blocks and programs that are combined in different ways,” explained study leader Prof. Dr. Marco Prinz, Medical Director of the Institute of Neuropathology at the University Hospital Freiburg and a member of the Centre for Integrative Biological Signalling Studies (CIBSS) at the University of Freiburg. These building blocks include protecting nerve cells, inflammatory responses, cell division, and activating other brain cells. “This helps us to describe disease-relevant processes more precisely and to better identify potential starting points for future therapies.”
The study focused on microglia, immune cells that are permanently present in the brain. These cells monitor nervous tissue, clear cellular debris, and respond to inflammation, injury, or the degeneration of nerve cells. By examining immune cells from human brain tissue and comparing them to those in mouse models using both experimental and computational methods, researchers were able to demonstrate that key patterns of immune response observed in human tissue were as well present in similar forms in the animal models.
Researchers found that not only the *type* of immune response, but also its *location* within the affected tissue is significant. Dr. Chintan Chhatbar, first author of the study at the Institute of Neuropathology at the University Hospital Freiburg, stated, “It was crucial for us to see not only which programs the microglia have, but also where they occur in the diseased tissue.” This spatial context reveals which reactions are most likely directly linked to typical disease processes. For example, in Alzheimer’s disease, specific microglia activations were found near characteristic protein deposits, while in multiple sclerosis, they were more prevalent at the edges of lesions, and in brain tumors, in close proximity to tumor cells.
This work builds upon previous studies that mapped the distribution of individual cell types in the brain, adding a disease-spanning and spatially resolved perspective. The findings offer a crucial foundation for comparing the brain’s immune response across different diseases and pinpointing potential targets for treatment. Researchers plan to investigate which of these programs can be specifically influenced and what role they might play in future diagnostics, disease monitoring, and therapy. You can find the full study at https://doi.org/10.1038/s41590-026-02472-z.
Original publication title:A transcriptomic microglia taxonomy across mouse and human pathologies
DOI: 10.1038/s41590-026-02472-z
